Andrew L. Sochacki
Hematology | Hematology Oncology | Oncology
145 Michigan Street Northeast
Suite 3100
Grand Rapids, MI 49503
Suite 3100
Grand Rapids, MI 49503
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Cost-effective and scalable clonal hematopoiesis assay provides insight into clonal dynamics.
Journal: medRxiv : the preprint server for health sciences
Published: November 21, 2023
Cost-Effective and Scalable Clonal Hematopoiesis Assay Provides Insight into Clonal Dynamics.
Journal: The Journal of molecular diagnostics : JMD
Published: November 09, 2023
Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation risk.
Journal: Blood cancer journal
Published: September 05, 2023
Patient-specific comorbidities as prognostic variables for survival in myelofibrosis.
Journal: Blood advances
Published: October 08, 2021
Mutational landscape of myelodysplastic/myeloproliferative neoplasm-unclassifiable.
Journal: Blood
Published: September 23, 2018
Therapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromes.
Journal: OncoTargets and therapy
Published: May 05, 2016
N-3 polyunsaturated Fatty acids prevent diabetic retinopathy by inhibition of retinal vascular damage and enhanced endothelial progenitor cell reparative function.
Journal: PloS one
Published: September 04, 2012
Showing 1-7 of 7
Last Updated: 09/26/2026